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Abstract 
 
Background: Structural brain abnormalities in schizophrenia have been repeatedly demonstrated in magnetic resonance 
imaging (MRI) studies, but it remains unclear whether these are static or progressive in nature. While longitudinal MRI 
studies have been traditionally used to assess the issue of progression of brain abnormalities in schizophrenia, information 
from cross-sectional neuroimaging studies directly comparing first-episode and chronic schizophrenia patients to healthy 
controls may also be useful to further clarify this issue. With the recent interest in multisite mega-analyses combining 
structural MRI data from multiple centers aiming at increased statistical power, the present multisite voxel-based 
morphometry (VBM) study was carried out to examine patterns of brain structural changes according to the different 
stages of illness and to ascertain which (if any) of such structural abnormalities would be specifically correlated to potential 
clinical moderators, including cumulative exposure to antipsychotics, age of onset, illness duration and overall illness 
severity. 
 
Methods:  We gathered a large sample of schizophrenia patients (161, being 99 chronic and 62 first-episode) and controls 
(151) from four previous morphometric MRI studies (1.5 T) carried out in the same geographical region of Brazil. Image 
processing and analyses were conducted using Statistical Parametric Mapping (SPM8) software with the diffeomorphic 
anatomical registration through exponentiated Lie algebra (DARTEL) algorithm. Group effects on regional gray matter (GM) 
volumes were investigated through whole-brain voxel-wise comparisons using General Linear Model Analysis of Co-
variance (ANCOVA), always including total GM volume, scan protocol, age and gender as nuisance variables. Finally, 
correlation analyses were performed between the aforementioned clinical moderators and regional and global brain 
volumes. 
 
Results: First-episode schizophrenia subjects displayed subtle volumetric deficits relative to controls in a circumscribed 
brain regional network identified only in small volume-corrected (SVC) analyses (p<0.05, FWE-corrected), including the 
insula, temporolimbic structures and striatum. Chronic schizophrenia patients, on the other hand, demonstrated an 
extensive pattern of regional GM volume decreases relative to controls, involving bilateral superior, inferior and orbital 
frontal cortices, right middle frontal cortex, bilateral anterior cingulate cortices, bilateral insulae and right superior and 
middle temporal cortices (p<0.05, FWE-corrected over the whole brain). GM volumes in several of those brain regions were 
directly correlated with age of disease onset on SVC analyses for conjoined (first-episode and chronic) schizophrenia 
groups. There were also widespread foci of significant negative correlation between duration of illness and relative GM 
volumes, but such findings remained significant only for the right dorsolateral prefrontal cortex after accounting for the 
influence of age of disease onset. Finally, significant negative correlations were detected between life-time cumulative 
exposure to antipsychotics and total GM and white matter volumes in schizophrenia patients, but no significant relationship 
was found between indices of antipsychotic usage and relative GM volume in any specific brain region. 
 
Conclusion: The above data indicate that brain changes associated with the diagnosis of schizophrenia are more 
widespread in chronic schizophrenia compared to first-episode patients. Our findings also suggest that relative GM volume 
deficits may be greater in (presumably more severe) cases with earlier age of onset, as well as varying as a function of 
illness duration in specific frontal brain regions. Finally, our results highlight the potentially complex effects of the 
continued use of antipsychotic drugs on structural brain abnormalities in schizophrenia, as we found that cumulative doses 
of antipsychotics affected brain volumes globally rather than selectively on frontal-temporal regions.  
  
Keywords: voxel-based morphometry; MRI; schizophrenia. 
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1. Introduction 
Structural brain abnormalities have been repeatedly demonstrated in groups of patients with 
schizophrenia compared to healthy controls in magnetic resonance imaging (MRI) studies, with some 
of the findings being observed at (or even before) the onset of illness [1-6]. However, it is not clear 
whether such structural brain changes are static or progressive in nature [2, 7-12].  
Although longitudinal MRI studies have been traditionally used to address the question of 
progression of brain abnormalities in schizophrenia, information from cross-sectional neuroimaging 
studies may also provide useful contributions to further clarify this issue [13]. Cross-sectional MRI 
comparisons of patients with first-episode and chronic schizophrenia are of interest because if there 
are more widespread brain changes in chronic than in first-episode psychosis, then this could imply a 
progression of brain anatomical changes after symptom onset [3]. Moreover, if structural brain 
changes are less widespread in first-episode schizophrenia, then the foci of such abnormalities could 
be seen as the critical brain regions of neuropathology from which continuing abnormalities may 
evolve to further, more widespread anatomical changes in chronic schizophrenia [3]. However, such 
cross-sectional approach has hitherto been applied primarily in meta-analytic investigations that 
indirectly compared groups of MRI studies on first-episode versus groups of studies on chronic 
schizophrenia [2, 3, 10, 12, 14]. Conversely, original cross-sectional MRI studies directly comparing 
first-episode and chronic schizophrenia patients to controls selected from the same geographical 
area have been very scarce to date [15]. Not infrequently, cross-sectional MRI studies actually pool 
together both chronic and first-episode patients [16-18], do not explicitly report the duration of 
illness [19-21], or even do not apply strict criteria to define these patient groups in regard to the 
stage of illness [22]. 
Recently, there has been growing interest in multisite mega-analyses combining structural 
MRI data from multiple centers through a uniform procedure of preprocessing and analysis, aiming 
at increased sensitivity and statistical power to detect group differences and investigate within-group 
correlations with clinical variables [23-28]. Three of these multisite MRI studies have evaluated 
subjects with schizophrenia applying the voxel-based morphometry (VBM) approach [24, 27, 28], 
whereby differences in gray matter (GM) volumes between schizophrenia patients and controls were 
investigated on a voxel-by-voxel basis across the entire brain. Also, the increased statistical power 
arising from VBM studies with large samples may help to disentangle to what extent progression of 
brain changes may be a consequence of an ongoing pathophysiological process in schizophrenia or a 
result of potential clinical moderators such as antipsychotics usage, for example. This is relevant 
since recent studies have suggested that antipsychotics, the cornerstone of the treatment of 
schizophrenia, may be significantly associated to some of the progressive neuroanatomical changes 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
previously reported in some MRI studies of schizophrenia, even after accounting for other potential 
moderators such as disease duration, illness severity and substance abuse [29-31]. Moreover, VBM 
studies using large schizophrenia and control samples may also afford statistical power to evaluate 
the potential influence of other clinical moderators on GM volumes, such as duration of illness and 
the overall severity of schizophrenia clinical features. 
In the present cross-sectional, multisite VBM study, we sought to replicate findings of brain 
structural changes in schizophrenia reported in previous large-sized VBM investigations [2, 3, 10, 12, 
14] by comparing groups of first-episode and chronic patients relative to demographically matched 
controls, all recruited in the state of São Paulo, Brazil. We hypothesized that chronic schizophrenia 
patients would have a more spatially widespread pattern of brain volume abnormalities than first-
episode schizophrenia patients. Also, we aimed to ascertain which (if any) of such structural brain 
changes would be specifically correlated to potential clinical moderators including cumulative 
exposure to antipsychotics, age of onset, illness duration and overall illness severity.    
 
2. Methods 
 
2.1 Subjects 
The present investigation gathered a large sample of schizophrenia patients and controls 
from four previous morphometric MRI studies carried out in medical institutions of two cities located 
in the same geographical region of Brazil (São Paulo State), namely the University of São Paulo 
Medical School in São Paulo city, and the University of São Paulo Medical School in Ribeirão Preto 
city. Such MRI studies had been carried out to address different research questions and their 
separate results have been published elsewhere [32-35]. All participants provided written informed 
consent at the time of the original MRI studies, and permission for this multisite data analysis was 
obtained from the ethical review board at University of São Paulo Medical School. We included a 
total of 312 non-overlapping subjects, being 161 schizophrenia patients (99 chronic, 62 first-episode) 
and 151 controls who underwent 1.5T structural T1-weighted MRI scanning. In studies of this kind, 
carried out with the primary aim to dichotomize schizophrenia samples regarding illness duration, 
great care must be taken to assure that chronic schizophrenia samples have strictly distinct median 
duration of disease in comparison to their counterpart, i.e., the first-episode sample. Therefore, 
when selecting studies for this mega-analysis we adopted a rigid criterion to define illness chronicity, 
as applied elsewhere [10]: median illness duration could not be less than 5 years in each study 
involving chronic schizophrenia patients [32, 33, 35]; similarly, the selected first-episode 
schizophrenia subjects  [34] had a median duration of illness of less than 1 year [10].   
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Chronic schizophrenia patients were recruited at local outpatient clinics at the Institute of 
Psychiatry of University of São Paulo [32, 33] and the University Hospital of the Faculty of Medicine 
of Ribeirão Preto [35]. Differently, first-episode schizophrenia patients [34] were drawn from a 
sample of people with first-episode psychosis identified for an epidemiological study of the incidence 
of psychotic disorders in São Paulo [36]; people presenting with a psychotic illness and who made 
contact for the first time with the mental healthcare services for that region (a circumscribed 
geographical area of São Paulo comprising a total of approximately 900 000 inhabitants) were 
recruited by active surveillance.  
Inclusion criteria for schizophrenia subjects were: diagnosis of schizophrenia according to 
DSM-IV criteria on the basis of interviews with the Structured Clinical Interview for DSM-IV Axis I 
Disorders  for all studies [37]; and an age at the time of MRI scanning ranging between 18 to 50 years 
in three studies [32, 34, 35], and 18 to 60 years in the remaining study [33]. People with psychotic 
disorders due to a general medical condition or substance-induced psychosis were excluded.  
In three of the MRI studies [32, 33, 35], healthy controls were recruited from the local 
community through local advertisements or invited by word of mouth, which in one study also 
included members from the staff at the Institute of Psychiatry at the University of São Paulo Medical 
School in São Paulo city [32]. For the remaining MRI study (the study on first-episode patients) [34], 
an epidemiological approach was applied for the recruitment of controls, randomly selecting a large 
group without psychosis from the same geographical area, comprised by next-door neighbors from 
first-episode patients; such population-based approach was used in that study in order to minimize 
the chance of selection bias (32). 
Exclusion criteria specific for the control group were personal history of other Axis I disorders 
(as determined by interviews using the SCID) [32, 33, 35] or psychosis [32-35]. Additional exclusion 
criteria for both groups were: history of head injury [32-35]; presence of neurological disorders or 
any organic disorders that could affect the central nervous system [32-35]; previous treatment with 
steroid medication [33]; contraindications for MRI scanning [32-35]; major medical illnesses [35]; and 
substance abuse [33, 35].  
Detailed sociodemographic and clinical data were retrieved from schizophrenia patients of 
each site. Although different scales for psychopathology severity were originally published in each 
study [32-35], scores of the Positive and Negative Syndrome Scale (PANSS) [38] were commonly 
available in most of the databases [32-34], except for one [35]; therefore, for the present mega-
analysis, symptom severity was rated using the PANSS, using only the three samples that had these 
data available.  
We also collected data on antipsychotics usage (typical or atypical drugs, duration of 
exposure, dose at the time of MRI scanning and lifetime cumulative exposure). Given that many 
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schizophrenia patients are maintained on antipsychotic treatment for long periods, it is useful to 
quantitatively assess cumulative medication exposure, especially because recent studies have 
highlighted the potential association between structural brain changes and use of antipsychotics in 
schizophrenia [29, 31, 39-41]. In order to calculate lifetime cumulative antipsychotic exposure, we 
first converted antipsychotic doses to chlorpromazine (CPZ) milligram equivalent units [42]. We 
subsequently calculated, for each patient, total cumulative exposure expressed in dose-years [42]. In 
cases of chronic antipsychotics exposure, it is worth mentioning that antipsychotic treatment is 
naturalistic and patients usually receive a standard treatment at discretion of treating psychiatrist 
[29]. Thus, in large, multisite studies like ours, by using retrospective methods (chart reviews), 
available data on antipsychotics may be heterogeneous and somewhat limited, making it difficult to 
obtain measurements of lifetime antipsychotic exposure with accuracy [29]. Therefore, we derived 
cumulative antipsychotic exposure using a product of defined daily dose and duration of illness as 
determined from patients’ charts. This index can be taken as an approximate measure of lifetime 
antipsychotic exposure [43].  
 
2.2 MRI acquisition and image processing 
High-resolution T1-weighted images were acquired in four different sites of the two medical 
institutions, with imaging parameters as summarized in Table 1.  Prior to data processing, all scans 
successfully passed a quality assessment protocol, based on visual inspection for gross structural 
abnormalities, artifacts, or poor image quality that could potentially hamper image segmentation. 
Imaging data processing and analysis were carried out using VBM methods based on the Statistical 
Parametric Mapping 8 software package (SPM8; Wellcome Trust Centre for Neuroimaging; 
http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) run in MATLAB (Mathworks, USA). Briefly, 
following manual reorientation in order to place the anterior commissure at the origin of the three-
dimensional Montreal Neurological Institute (MNI) coordinate system, T1-W images were segmented 
into tissue classes of GM, white matter (WM), and cerebrospinal fluid (CSF) by using the standard 
unified segmentation model in SPM8 [44], which makes use of tissue probability maps reflecting the 
prior probability of a given voxel belonging to any tissue class [44]. The Diffeomorphic Anatomical 
Registration Through Exponentiated Lie Algebra (DARTEL) algorithm [45] was employed to create a 
study-specific template for spatial normalization of the segmented images of each subject. 
The resulting flow fields created by DARTEL were used to generate GM and WM images of 
each individual; such images were spatially normalized in the MNI space, modulated, resliced (1.0-
mm isotropic voxels), and smoothed (8-mm full-width at half maximum Gaussian kernel). In order to 
compensate for the effects of spatial normalization, GM and WM normalized images are modulated 
by multiplying each voxel value by its relative volume before and after warping, which allows 
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obtaining relative volume for each voxel; the maps so produced are referred to as images of GM and 
WM volumes in order to distinguish them from the images of “concentration” or “density” that result 
if the modulation stage is omitted [27, 46]. Therefore, volumes of GM, WM and CSF were calculated 
by the MATLAB get_totals script (http://www.cs.ucl.ac.uk/staff/g.ridgway/vbm/get_totals.m) 
implemented for SPM8 on the native space gray, white, and cerebrospinal fluid segmentations for 
each subject. Similarly, to compute total intracranial volume (TIV) using SPM's unified segmentation 
and spatial normalization procedure, probabilistic tissue class images can be integrated, with the 
estimated TIV simply being the sum of GM, WM and CSF volumes [47-49], as herein adopted. Total 
brain volume (TBV) was estimated by summing GM and WM volumes [50]. However, tissue prior 
probability templates used in SPM are based on averaging multiple automatically segmented images 
in standard space, with no certainty that the sum of these three compartments will be exactly 
consistent with accepted definitions of TIV [49]. For instance, such automated method of TIV 
estimation in SPM8 was found to overestimate TIV by 20.86 % as compared to manual segmentation 
[50], these errors being shown to impact the ability to detect differences in hippocampal volume, for 
example [50]. It is expected that improved new segmentation algorithms incorporated into SPM8 
and SPM12 can produce more accurate TIV results, despite current evidence for this are yet scarce 
[49].  
Finally, in order to ensure that all images were segmented adequately, subject outlier 
detection was performed within and across the four sites using a Pearson correlation, by comparing 
the degree to which subjects were related to the average smoothed GM map. Outliers were defined 
as subjects deviating more than 2% from the mean GM volumes, according to criteria defined 
elsewhere [27]; no outlier was identified. 
 
2.3 Statistical analysis 
Group differences in demographic characteristics were assessed with IBM SPSS Statistics, 
version 21 (IBM, Armonk, USA). The significance threshold was set at 0.05, two-tailed; continuous 
variables were analyzed through the t test and categorical variables through Pearson’s χ2 test. 
Regarding the VBM analyses, group effects on regional GM volume were investigated 
through whole-brain voxel-wise comparisons of the preprocessed GM images of schizophrenia 
patients and controls by using General Linear Model (GLM) Analysis of Co-variance (ANCOVA), which 
always included total GM volume, scan protocol, age and gender as nuisance variables (hereafter 
defined as “standard covariance”). Moreover, within-group correlations were performed between 
regional brain volumes and potential clinical moderators [psychopathology severity (as assessed by 
PANSS total score, after excluding subjects of one study with unavailable data [35]), life-time 
cumulative exposure to antipsychotics (as assessed by estimation of dose-years), age of onset and 
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duration of illness], always correcting for the effects of the remainder potential clinical moderators, 
in addition to the standard covariance. 
It has been previously described that variations in the choice of method for adjusting VBM-
based regional GM volume indices for global GM (total GM, TGM, i.e., the sum of GM across all 
voxels) may significantly affect results when making inferences about regional brain volume changes 
[51]. Accordingly, we conducted additional VBM analyses using three alternative methods of 
covariation for global GM, as described elsewhere [51]. First, for each individual, we calculated TGM 
as the sum of GM across brain regions using unregistered, unsmoothed MRI datasets [51]. 
Subsequently, using the aforementioned definition of TIV, the following VBM analyses were 
performed: no adjusting for TGM, with and without total intracranial volume (TIV) being considered; 
global scaling, by proportionally scaling each participant's GM image by the TGM from that image 
(i.e., each participant's smoothed normalized GM image was divided by the TGM for that 
participant), with and without TIV being considered; and local covariation, by including each 
participant's TGM as an additional covariate of no interest in an ANCOVA, with and without TIV being 
considered [51]. Results of such analyses were subsequently compared to those of our conventional 
approach in order to verify if the neuroanatomical pattern and level of extension of regional GM 
changes were substantially affected in this study according to the method of global adjusting.  
For all VBM analyses, the statistics for each voxel of the whole GM compartment were 
transformed to Z scores and displayed as statistical parametric maps (SPMs) in standard MNI space 
at an initial threshold probability of Z> 3.09 (p< 0.001, uncorrected), with cluster size threshold of 20 
contiguous voxels [52, 53]. When examining the voxelwise statistical maps, we did not consider 
significant findings with spatial patterns primarily around the edges of the brain, in regions subject to 
artifact of partial volume and deskulling problems [18, 24]. Statistical inference was conducted in two 
steps. Initially, we used a strict statistical threshold of p<0.05, familywise error (FWE)-corrected for 
multiple comparisons over the whole brain. Second, we applied small volume correction (SVC) over 
the following brain regions predicted a priori to show abnormalities in schizophrenia patients, based 
on recent meta-analyses and mega-analyses of structural MRI studies on schizophrenia [10, 54, 55]: 
insula, dorsolateral prefrontal cortex, superior temporal gyrus, amygdala, hippocampus/ 
parahippocampal gyrus, anterior cingulate cortex, thalamus and striatum. Such brain regions were 
spatially delimited by applying normalized volumes onto the SPMs, based on the anatomical volumes 
of interest that are available within the automatic anatomical labeling SPM toolbox. Such flexible 
statistical analyses were conducted using a FWE-corrected threshold of p<0.05 over the volume of 
the SVC-based region, also with cluster size threshold of 20 contiguous voxels. The SVC approach 
allows hypothesis-driven analyses to be performed with correction for multiple comparisons 
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specifically in the brain region of interest rather than using a stricter correction for the whole brain 
[34].  
Finally, for the conjoined group (chronic + first-episode), as well as for the chronic and first-
episode groups separately, we also performed bivariate correlation analyses (Pearson product-
moment correlation, two-tailed, p<0.05) between global volume values (GM, WM, CSF, TBV and TIV) 
and the following clinical moderators: psychopathology severity [as assessed by PANSS total score, 
after excluding subjects of one study with unavailable data [35]], life-time cumulative exposure to 
antipsychotics (as assessed by estimation of dose-years), duration of illness, and age of onset. The 
effects of the remainder clinical variables on the results of correlation analyses between a given 
clinical moderator and global brain volumes were also accounted for through partial correlation 
analyses (two-tailed, p<0.05).  
In order to give a general overview of the main VBM findings of the study, regardless of as to 
whether they were significant in the whole-brain exploratory analyses (at strict statistical significance 
levels) or in the (more flexible) SVC-based analyses, all figures were constructed based on statistical 
parametric maps thresholded at p<0.001 (uncorrected for multiple comparisons) with a minimum 
cluster extent of 10 voxels, as employed elsewhere [23]. 
 
3. Results  
3.1 Demographic and clinical variables 
Sociodemographic and clinical data are listed in Table 2. Patients and controls did not differ 
in terms of age, but there was a significantly higher male predominance among schizophrenia 
patients in comparison to controls, as well as significantly fewer years of education in schizophrenia 
patients (Table 1). Chronic schizophrenia patients did not differ from first-episode schizophrenia 
patients regarding gender, but they were significantly older than first episode schizophrenia patients, 
had higher number of years of education, a lower age of illness onset and higher PANSS scores (Table 
2). Most chronic schizophrenia patients were on atypical antipsychotics usage, while typicals were 
the most common antipsychotic class among first episode schizophrenia patients, this difference 
being statistically significant (Table 2). As would be expected, chronic schizophrenia patients had 
higher life-time cumulative exposure to antipsychotics.  
 
3.2 Global volume analyses 
Patients and controls did not differ in terms of total GM or WM volumes, TBV and TIV (Table 
3). Patients with schizophrenia had higher CSF volumes that controls (p<0.0001). Chronic 
schizophrenia patients did not differ from first-episode patients regarding total GM or WM volumes, 
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but CSF volumes were larger (p<0.0001) among chronic in comparison to first-episode patients (Table 
3). However, this difference did not remain statistically significant when the effect of age of onset 
was accounted for (Table 3). 
Bivariate correlation analyses revealed significant negative correlations between life-time 
cumulative exposure to antipsychotics and global volumes for both the conjoined group [(total GM, 
r=-0.244, p=0.002); (total WM, r=-0.177, p=0.025); (TBV, r= -0.218, p=0.005); (TIV, r=-0.157, p=0.047)] 
and for the chronic schizophrenia group [(total GM, r=-0.372, p=0.000); (total WM, r=-0.208, 
p=0.039); (TBV, r= -0.305, p=0.002); (TIV, r=-0.271, p=0.007)]. When these analyses for antipsychotic 
exposure were repeated in the chronic schizophrenia group with covariance for disease duration, 
both the negative correlations with total GM (r=-0.207, p=0.044) and TBV (r=-0.202, p=0.044) 
retained statistical significance, while the negative correlations with total WM (r=-0.188, p= 0.067) 
and TIV (r=-0.186, p=0.071) remained as significant trends. Repeated analyses for the conjoined four 
groups with covariance for disease duration indicated trend significance for the negative correlation 
between total GM and antipsychotic exposure (r=-0.143, p=0.075).  
For the conjoined group only, a significant positive correlation was found between CSF 
volumes and duration of disease (r=0.237; p=0.002). However, this finding lost its statistical 
significance after covariance for antipsychotic exposure and age of disease onset (r= 0.027, p= 0.741). 
No significant correlations between severity of disease and global volumes were found for 
any group. 
 
3.3 Regional brain volume analyses: VBM findings of between-group comparisons 
The VBM analysis of main effect of diagnosis, under the strict threshold of p<0.05 (FWE-
corrected) and minimum cluster extent of 20 voxels over the whole brain, revealed a pattern of 
cortical volume deficits restricted to the bilateral insulae, right striatum and left inferior frontal gyrus 
when contrasting all schizophrenia patients versus healthy controls (Figure 1, Table 4). Small volume-
corrected analyses revealed reduced GM volumes in schizophrenia patients relative to controls in the 
following additional brain regions predicted a priori to show abnormalities: bilateral dorsolateral 
prefrontal cortices, bilateral anterior cingulate cortices, bilateral thalami and left hippocampus/ 
parahippocampal gyrus. The voxel extent of such findings and corresponding Z-scores are provided in 
Table 4.  
There were no regional GM volume deficits in the first-episode schizophrenia sample relative 
to controls at FWE-corrected analyses over the whole brain. Small volume-corrected analyses 
revealed reduced GM volumes in first-episode schizophrenia patients in the following brain regions 
predicted a priori to show abnormalities: bilateral insulae, right amygdala, right striatum and right 
hippocampus/ parahippocampal gyrus (Figure 2). The voxel extent of such findings and 
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corresponding Z-scores are provided in Table 5. As a secondary analysis, we carried out a voxelwise 
comparison of regional WM volumes between FES subject and controls; this revealed no significant 
findings (at the FWE-corrected p<0.05 level over the whole brain). 
The sample of chronic schizophrenia patients presented a more extensive pattern of regional 
GM volume decreases relative to controls (Figure 3a), involving the bilateral superior, inferior and 
orbital frontal cortices, right middle frontal cortex, bilateral anterior cingulate cortices, bilateral 
insulae, right superior and middle temporal cortices, left postcentral gyrus, left fusiform gyrus, right 
thalamus, right supramarginal gyrus, left precentral gyrus, right calcarine gyrus, left median cingulate 
and paracingulate gyri, and left hippocampus/parahippocampal gyrus (FWE-corrected analyses over 
the whole brain), as shown in Table 6. Small volume-corrected analyses revealed reduced GM 
volumes in the following additional brain regions predicted a priori to show abnormalities: left 
thalamus, right hippocampus/ parahippocampal gyrus, and right superior temporal gyrus. The voxel 
extent of such findings and corresponding Z-scores are provided in Table 6. 
In comparison to first-episode patients, chronic schizophrenia patients showed extended GM 
decreases (Figure 3b) within the bilateral superior and middle temporal cortices, extending to left 
parahippocampal gyrus and to parietal and occipital structures (bilateral angular gyri, right 
supramarginal gyrus, and left inferior occipital, fusiform and lingual cortices); other brain regions 
involved were the left inferior frontal cortex, left superior and inferior parietal cortices, as well as left 
precentral and postcentral cortices, and left insula (FWE-corrected analyses over the whole brain), as 
shown in Table 7. Small volume-corrected analyses revealed reduced GM volumes in the following 
additional brain regions predicted a priori to show abnormalities: right thalamus and right amygdala. 
The voxel extent of such findings and corresponding Z-scores are provided in Table 7.  
At the p<0.05 (FWE-corrected) statistical threshold over the whole brain, there were no 
significant findings of regional GM volume increases detectable in the between-group comparisons 
above.  
Regarding the different methods of covariation for total GM, although subtle variations in the 
magnitude of VBM findings were found in comparison to our standard approach, the 
neuroanatomical pattern of regional changes was maintained, suggesting that results of this study 
were not substantially affected by the method of global covariation.  
 
3.4 Effects of age of disease onset on regional volume analyses (VBM) 
When we repeated the above comparison between chronic and first-episode schizophrenia 
patients including age of onset as a confounding covariate, we detected a similar pattern of regional 
GM volume deficits in chronic patients relative to first-episode subjects. There were extensive GM 
decreases within the bilateral superior and middle temporal cortices, right superior and inferior 
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frontal cortices, left precentral and postcentral cortices, and right occipital structures (calcarine, 
precuneus, cuneus and lingual cortices); other brain regions involved were the right thalamus, 
bilateral inferior parietal cortices and left superior parietal cortex  (p<0.05, FWE-corrected over the 
whole brain) (Table 8). Small volume-corrected analyses revealed reduced GM volumes in the 
following additional brain regions predicted a priori to show abnormalities: bilateral anterior 
cingulate cortices, left striatum, bilateral hippocampi/ parahippocampal gyri, bilateral insulae and left 
thalamus. The voxel extent of such findings and corresponding Z-scores are provided in Table 8.  
In the investigation of within-group correlations between regional brain volumes and age of 
onset, we found (only in SVC-corrected analyses) positive correlations involving the bilateral insulae 
and anterior cingulate and dorsolateral prefrontal cortices, the right hippocampus/ parahippocampal 
gyrus and right superior temporal gyrus for the conjoined four groups, after accounting for the 
effects of life-time cumulative exposure to antipsychotics. When additionally accounting for the 
effects of illness severity (in the conjoined three groups with available PANSS total scores), the foci of 
positive correlation in the left anterior cingulate cortex, bilateral dorsolateral prefrontal cortices, left 
insula, right hippocampus/ parahippocampal gyrus and right superior temporal gyrus all remained 
statistically significant. The voxel extent of these findings and their corresponding Z-scores are 
provided in Table 9.  
 
3.5 Regional volume analyses: VBM findings of other significant within-group correlations 
No significant positive or negative correlations between other potential clinical moderators 
(psychopathology severity, as assessed by PANSS total score; life-time cumulative exposure to 
antipsychotics, as assessed by estimation of dose-years; and duration of illness) and regional brain 
structural changes were found for any of the patient subgroups when analyses were performed 
under the strict threshold of p<0.05, FWE-corrected over the whole brain.  
In regard to small volume-corrected analyses, one cluster of significant negative correlation 
was detected in the first-episode schizophrenia group between duration of disease and GM volume 
of the left superior temporal gyrus (with covariance for lifetime cumulative exposure to 
antipsychotics, overall illness severity and age of onset). The voxel extent of this finding and its 
corresponding Z-score are provided in Table 10.  
In the conjoined four groups, small volume-corrected analyses revealed several foci of 
significant negative correlation between duration of illness and GM volumes in the bilateral insulae, 
dorsolateral prefrontal cortices and hippocampi/ parahippocampal gyri, after accounting for effects 
of lifetime cumulative exposure to antipsychotics (Table 10). There were additional significant 
negative correlations between duration of disease and GM volumes of the bilateral anterior cingulate 
cortices for the conjunction of the three groups with available PANSS total scores, after accounting 
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for effects of overall illness severity and lifetime cumulative exposure to antipsychotics (Table 10). 
However, when these negative correlations were recalculated including age of onset as an additional 
confounding covariate, only a cluster in the right dorsolateral prefrontal cortex retained statistical 
significance, in the conjoined three groups with available PANSS total scores (Table 10). 
 
 
 
4. Discussion 
This large cross-sectional VBM multisite mega-analysis compared groups of schizophrenia 
patients (n=161) and healthy controls (n=151) recruited in the same geographical region. While first-
episode schizophrenia subjects displayed subtle and highly circumscribed GM volume reductions in 
the brain relative to controls, chronic schizophrenia patients had more significant and widespread 
cortical GM deficits. In some brain foci, relative regional GM volumes were directly correlated with 
age of disease onset. Also, global brain volumes in schizophrenia were inversely related to the degree 
of exposure to antipsychotic drugs. While the results of our between-group comparisons provide 
replication to the findings of a number of previous MRI studies of schizophrenia [2, 3, 10, 12, 14], the 
relevance attributed to the potential influence of clinical moderators in our analyses is unique to 
date, and allowed us to unveil some novel findings. 
 
4.1 Gray matter volume abnormalities associated with first-episode schizophrenia 
The comparison of first-episode schizophrenia subjects against controls identified regional 
GM volume deficits in the former group in a circumscribed network of brain regions including the 
insula, temporolimbic structures (hippocampus/parahippocampal gyrus/amygdala) and striatum. 
Volume reductions in these brain regions have been often reported in previous VBM investigations of 
schizophrenia, despite some degree of variation across separate studies and meta-analyses [3, 10, 
14, 56, 57]. In our investigation, these brain volume abnormalities were subtle, being uncovered only 
when the more flexible SVC approach was applied.  
The involvement of the insula in the pathophysiology of schizophrenia has been sometimes 
seen simply as an “extension” of primary frontal and temporal lobe pathology [10, 58]. The relatively 
circumscribed findings of brain abnormalities in our first-episode schizophrenia sample, highlighting 
GM deficits in the insula, are not consistent with such view. Instead, the selective brain volume 
deficits in our first-episode schizophrenia sample, involving specifically the insula and temporolimbic 
structures, suggest that these foci of volume abnormalities should be seen as critical brain regions of 
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neuropathology from which continuing abnormalities may evolve to further, widespread anatomical 
changes in chronic schizophrenia [3, 59].  
The insula plays a critical role in emotional processing, integration of sensory (visual and 
auditory) input with the limbic system, pain perception, as well as being uniquely involved in 
interoception and neural representations of the self [58]. Since the latter role allows discriminating 
between self-generated and external information, it has been suggested that insular dysfunction may 
contribute to hallucinations, a cardinal feature of schizophrenia [58]. The insula has extensive 
connections with many areas of the cerebral cortex, and may act as an interface between the frontal 
and temporal lobes. Temporolimbic structures are part of a network that integrates external and 
internal information, mediating physiological, behavioral, and psychological responses, as well as 
leading to emotion-based decisions that allow for adaptation to the environment on the basis of 
previous experience [60]. In addition, the medial temporal cortex is a critical component of the 
neural network involved in pleasure and reward [60]. Dysfunction of temporolimbic structures is 
thought to critically contribute to the emergence of key clinical features of schizophrenia, including 
both positive and negative symptoms [60]. 
While none of the large multi-site cross-sectional VBM investigations of schizophrenia to 
date assessed first-episode schizophrenia patients separately, a number of single-site MRI studies 
have evaluated relatively large first-episode schizophrenia samples [15, 61-64]. In the largest single-
site cross-sectional VBM study of schizophrenia to date, Meisenzahl et al. [15] found GM volume 
reductions in several brain regions in first-episode schizophrenia patients relative to healthy controls, 
affecting most significantly the perisylvian areas bilaterally, as well as the left insula, superior 
temporal gyrus, amygdala and hippocampus. Other bilateral GM volume reductions were found in 
the cingulate, orbitofrontal, dorsolateral and dorsomedial prefrontal cortices, gyrus rectus, and 
thalami [15]. Despite the absence of significant findings involving notably the superior temporal 
gyrus in our study (relative reduction in the left superior temporal gyrus is the most significant 
finding in more than 50% of VBM studies of schizophrenia according to a meta-analysis [14]), the 
results of Meisenzahl et al. [15] are still partially in agreement with ours especially regarding the 
insular and temporo-limbic GM volume abnormalities in first-episode schizophrenia patients. In 
accord with our findings, other VBM studies that evaluated relatively large first-episode 
schizophrenia samples have also detected GM volume reductions in circumscribed regions rather 
than in a widespread fashion throughout the brain [15, 61-64]. 
The first-episode schizophrenia sample included in the present study is the same evaluated 
previously by our group in a VBM investigation using a less optimized (SPM 2) version of the image 
processing software employed herein [34]. The fact that the same significant results emerged in the 
insula and temporolimbic structures across the two investigations suggest the robustness of the 
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findings implicating these two brain regions in first-episode schizophrenia. However, first-episode 
schizophrenia patients in the present investigation did not display GM volume deficits in two 
additional brain regions thought to be relevant to schizophrenia and which were shown to present 
volume abnormalities in our previous paper [34], namely the left superior temporal gyrus (as 
mentioned above) and the inferior lateral prefrontal cortex. Similar statistical inference approaches 
were applied in the two studies, and the differences in the results obtained highlight the fact that 
variable VBM findings may emerge when distinct spatial normalization and other routines are 
employed for image processing [65-70]. Also, a larger control group was employed in the current 
investigation compared to our previous publication, including a proportion of healthy individuals that 
were not recruited in the same neighbourhood of the schizophrenia patients, as in our previous 
study  [34]. Nevertheless, it should be noted that the current SPM8-based analyses did allow 
detection of a significant finding involving the left superior temporal gyrus in the first-episode 
schizophrenia group, consisting of an inverse correlation between GM volume of this regions and 
disease duration before MRI scanning.  
 
4.2 Greater structural brain volume deficits in chronic schizophrenia patients 
Whether schizophrenia is characterized or not by progressive structural brain changes is of 
importance to further clarify the pathophysiology of the disorder. The neurodevelopmental 
hypothesis proposes that schizophrenia is a consequence of a disruption in early brain development, 
and that an interaction between early brain insults and later environmental factors would trigger the 
emergence of psychotic behavior and other overt symptoms of schizophrenia from early adulthood 
onwards [71, 72]. Evidence associating prenatal and perinatal complications with the diagnosis of 
schizophrenia later in life, absence of gliosis in the brains of schizophrenia patients as evaluated in 
postmortem studies, and detection of structural brain changes by MRI before illness onset, have all 
been taken to support the neurodevelopmental model for schizophrenia [5, 6, 73, 74]. However, the 
heterogeneous and sometimes deteriorating clinical course of schizophrenia suggests that 
neurodegenerative processes may also occur in schizophrenia, mainly in early stages after the onset 
of the illness [8, 75]. Evidence supporting the neurodegenerative hypothesis of schizophrenia 
includes findings from longitudinal neuroimaging studies showing progressive structural brain 
changes, such as cortical GM volume reductions and ventricular enlargement, in schizophrenia 
patients [76]. The hypothesis of neurodegeneration, however, has been controversial because the 
findings of different neuroimaging studies have at times been inconsistent, with some authors 
finding no brain volume changes over time [77] or even a reversal of GM decline in longitudinal MRI 
evaluations [78]. Differences in image analysis techniques, duration of follow-up intervals and clinical 
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characteristics of the schizophrenia samples recruited for each study may help to explain such 
heterogeneity in results of longitudinal MRI studies. 
In concordance with our initial hypothesis, we detected a more widespread pattern of 
structural GM changes in chronic than first-episode schizophrenia patients in comparison to controls. 
Such pattern of results might be taken to support the notion that brain changes associated with the 
diagnosis of schizophrenia progress over the course of the illness. Our findings of extensive GM 
deficits among chronic schizophrenia patients are consistent with the results of previous meta-
analyses that performed indirect comparisons between groups of first-episode and chronic 
schizophrenia patients [2, 3, 10, 12, 14]. Our findings are also in agreement with the results of the 
previous VBM-based mega-analysis by Meisenzahl et al. [15] which applied a similar cross-sectional 
design to analyze MRI data from schizophrenia patients and controls. Among chronic schizophrenia 
patients, Meisenzahl et al. [15] found extensive GM deficits involving the insula, dorsolateral and 
ventrolateral prefrontal cortices, anterior cingulate cortex, temporolimbic region (including the 
hippocampus, amygdala and parahippocampal gyrus) and superior temporal gyrus, as well as the 
caudate nuclei bilaterally. Interestingly, our results demonstrate a pattern of volume abnormalities in 
a very similar neuroanatomical circuitry, including GM volume deficits in insular, frontal and 
temporolimbic brain regions in chronic schizophrenia. Such a pattern of fronto-temporolimbic 
volume changes in chronic schizophrenia is also in accordance with the meta-analytic seminal 
findings by Ellison-Wright et al. [3]. Finally, regarding the results of previous multisite mega-analyses, 
Segall et al. [27] evaluated 503 subjects (237 chronic patients diagnosed with schizophrenia, 
schizoaffective or schizophreniform disorder and 266 controls) and reported a pattern of GM 
reductions in the group of patients relative to controls that was most pronounced in the inferior 
frontal gyrus, insula, parahippocampal gyrus, superior temporal gyrus, and rectal gyrus. Such 
abnormalities were even more widespread in a further, larger mega-analysis evaluating chronic 
schizophrenia patients by Gupta et al. [24] (1720 subjects; 784 schizophrenia patients and 936 
controls), which revealed structural alterations in regions that covered most of the brain in a single 
cluster (i.e., whole-brain volumetric reduction in schizophrenia). 
The convergent finding of large fronto-temporolimbic GM volumetric deficits in our analyses 
and the aforementioned studies of chronic schizophrenia subjects [15, 24, 27] is consistent with the 
relevance attributed to these brain regions in the pathophysiology of schizophrenia [2]. Fronto-
temporal regions have been implicated in a range of cognitive processes affected in schizophrenia, 
including attention, language, working memory and other aspects of executive functioning, as well as 
with the expression of different clinical features of schizophrenia [79]. The relevance of GM volume 
deficits in chronic schizophrenia affecting frontal brain regions is also highlighted in our study by the 
finding of a significant negative correlation between illness duration and GM deficits in schizophrenia 
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patients in the right dorsolateral prefrontal cortex, which remained significant after accounting for 
the effects of age of disease onset and degree of antipsychotic exposure.  
One issue when interpreting results of widespread brain volume deficits in samples of 
chronic schizophrenia patients is the extent to which such findings may vary specifically as a function 
of greater illness severity, rather than reflecting the continuation of schizophrenia over time. Cases 
of schizophrenia that are more severe could conceivably display, at the time of disease onset, greater 
brain abnormalities that may not necessarily progress over time [11]. In our study, a difference in the 
recruitment strategy between first-episode and chronic schizophrenia patients likely favoured the 
inclusion of more severe cases of schizophrenia in the latter group. For the recruitment of the first-
episode group, a team of researchers actively surveilled local mental health services in a predefined 
catchment area [34], thus allowing the recruitment of cases of varying degrees of severity in the 
schizophrenia spectrum; a follow-up investigation after a mean of 1.5 years actually revealed 
remission of symptoms in a significant minority of schizophrenia cases [80]. Conversely, our chronic 
schizophrenia patients were selected from tertiary hospital settings, thus potentially biasing the 
recruitment towards more severe cases, some of which with a history of recurrent hospital 
admissions. It is therefore likely that the finding of more widespread cortical GM volume deficits in 
our chronic schizophrenia group was influenced by the inclusion of more severe cases in that specific 
group, rather than simply reflecting the overall effects of greater illness duration in the chronic 
schizophrenia group. This possibility is reinforced by the fact that the chronic schizophrenia group in 
our study had substantially earlier disease onset relative to the first-episode group, since it is well 
known that earlier age of onset of schizophrenia is associated with worse outcome [81, 82]. 
Accordingly, our voxelwise search for correlations between regional GM volumes and clinical 
moderators indicated the presence of significant positive correlations between age of disease onset 
and GM volumes in several of the brain regions where chronic schizophrenia patients displayed 
reduced GM volumes in comparison to both first-episode patients and healthy controls.  
The notion that greater GM volume deficits in schizophrenia depends on clinical severity 
rather than simply reflecting illness chronicity is also supported by a number of recent longitudinal 
MRI studies of schizophrenia which have suggested that significant progression of brain volume 
deficits in schizophrenia over time relative to controls may be present predominantly in a subset of 
patients with more severe illness and worse prognosis [2, 83]. Included among those MRI 
investigations is a study in which a subset of the present first-episode schizophrenia sample was re-
scanned after a mean of 5 years, with findings of GM decrements over time being detected in 
selected cortical regions only in schizophrenia subjects with a more severe, non-remitting course of 
illness [84]. However, in this study, we did not find any significant correlations between regional 
brain volumes and overall illness severity, suggesting that such moderator may be part of a complex 
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interaction of factors with different weights on the brain structural abnormalities detectable in 
chronic schizophrenia. 
 
4.3 Relationship between brain volume deficits and antipsychotic use  
The continued use of antipsychotic medication has been previously highlighted as a 
potentially contributing factor influencing on the progression of GM volume deficits in chronic 
schizophrenia patients [30, 31, 85-87]. This possibility has been supported by studies in animals 
showing structural brain changes in association with chronic antipsychotic administration [88-90]. 
Recently, a meta-analysis of longitudinal MRI studies found progressive GM decreases among 
schizophrenia patients that were inversely correlated with cumulative exposure to antipsychotics, 
and such relationship could not be accounted for by illness duration or severity [30]. One other meta-
analysis of longitudinal MRI studies focusing on typicality of antipsychotics found a significant 
correlation between cumulative antipsychotic exposure and progressive GM deficits in schizophrenia, 
although such changes were less prominent among patients treated with second-generation 
antipsychotics [86].  
In contrast with the previous multisite VBM-based mega-analyses of schizophrenia [24, 27], 
we were able to carefully quantify the lifetime cumulative dosage of antipsychotics in our 
schizophrenia patients. With that strategy, we did find significant negative correlations between life-
time cumulative exposure to antipsychotics and global brain volumes in the schizophrenia group, 
after accounting for the effects duration of illness. Such results are consistent with findings of 
previous animal studies which have demonstrated diffuse reductions in brain volume and weight in 
macaque monkeys exposed to olanzapine or haloperidol compared to placebo [88] as well as meta-
analytic data from longitudinal MRI studies in schizophrenia patients showing that global GM volume 
decrements over time are related to cumulative exposure to antipsychotic treatments [30]. Thus our 
results gives support to the hypothesis that the continued use of antipsychotics may significantly 
influence the progression of neuroanatomical deficits in schizophrenia [11].  
It should be noted that we found no significant correlations between indices of antipsychotic 
exposure and relative regional GM volume deficits in schizophrenia patients. Therefore, we cannot 
attribute the findings of regional GM volume deficits located in fronto-temporal cortices in chronic 
schizophrenia subjects to the continued exposure to antipsychotic drugs [30, 31, 85-87]. In light of 
the results of the meta-analysis by Vita et al. [86], the preponderance of patients using second-
generation antipsychotics in our chronic sample (64 % vs. 36%) may have contributed to the absence 
of findings relating medication use to relative GM abnormalities affecting fronto-temporal regions in 
the present study.  
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The combined findings of our study regarding medication use, with effects on global rather 
than regional brain volumes in schizophrenia, are pioneer for a cross-sectional VBM mega-analysis. 
Nevertheless, this remains an open question, yet to be scrutinized in further mega-analyses of cross-
sectional and longitudinal MRI studies.  
 
4.4 Strengths and limitations 
Our study has several strengths. With our multisite study design, we gained statistical power 
by pooling together large samples of schizophrenia patients and demographically matched controls. 
The potentially confounding effects of heterogeneous image acquisition protocols were addressed by 
using a uniform image preprocessing pipeline and by entering site/scanning protocol in the GLM 
used for the statistical analysis. Previous technical reports have demonstrated that results of 
analyses performed by pooling together MRI datasets from multiple centers are not substantially 
confounded by scanner differences when such methodological approach is applied [91, 92]. Similar 
strategies have been employed in two previous mega-analyses of MRI datasets from schizophrenia 
patients and controls [24, 27]. Also, we conducted repeated analyses of regional GM volumes with 
covariance for different indices of global brain volumes, which varied in regard to the involvement of 
the distinct tissue compartments in the brain; the consistency of the results obtained in all analyses 
ensured that our regional GM volume findings were not influenced by global volume differences 
variably affecting different brain compartments in schizophrenia patients and controls. Finally, in 
contrast to the other multisite VBM studies of schizophrenia published to date, which gathered 
subjects from a wide range of geographical areas across USA and Europe [24, 27], our participants 
were drawn from only two urban centers separated by approximately 195 miles in the state of São 
Paulo, Brazil. Thus we potentially reduced variability of brain measurements related to geographical 
and environmental differences across separate MRI scanning sites [93].  
On the other hand, we acknowledge that our study is not without limitations. First, while 
attempting to assess the influence of various clinical moderators on GM volumes, we were unable to 
address the role of some other potentially relevant confounders evaluated in the previous 
neuroimaging literature on schizophrenia, such as changes in patterns of antipsychotic usage, 
treatment adherence, duration of untreated psychosis and substance abuse [7]. Also, we cannot rule 
out in our study the influence of other confounders that vary systematically between groups of 
patients with psychiatric disorders and controls, such as smoking habits, other cardiovascular risk 
factors and metabolic comorbidities [94]. Finally, it could be argued that the 1,5T magnetic field 
strength of all MRI scanners that provided data for this study could limit the results of our analyses. 
Although increasing the magnetic field strength from 1.5 to 3T theoretically would roughly double 
the signal-to-noise ratio, with consequent higher contrast-to-noise to better differentiate GM and 
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other tissues [95], conversely 3T magnetic resonance images often have an increased level of artifact 
[95, 96]. The latter aspect potentially affects the accuracy of automated algorithms that classify 
tissue into gray and white matter components [95, 97] as well as leading to local spatial distortion 
and artifactual local variations in image intensity [95]. Moreover, recent VBM [98, 99] and other 
structural MRI studies that used other image processing methods [95] have found no or little 
evidence of an impact of field strength on the results of analyses investigating brain abnormalities in 
patients with brain disorders. Finally, recent VBM multisite mega-analyses in schizophrenia were 
carried out using data acquired with different scanners at 1.5T, 3T and 4T and this factor has not 
been found to limit results and conclusions (i.e., in a subset of subjects scanned in two separate sites 
using different acquisition protocols, there was no significant interaction between the effects of 
scanner and group) [27]. 
 
4.5 Conclusion 
In conclusion, the results of this multi-site VBM study of schizophrenia carried out in Brazil 
reinforce the notion that structural brain changes associated with the diagnosis of schizophrenia are 
more widespread in chronic schizophrenia compared to first-episode patients, mainly affecting 
fronto-temporal regions and the insula. Our VBM findings of significant correlations also suggest that 
relative GM volume deficits may be greater in (presumably more severe) cases with earlier age of 
onset, as well as varying as a function of illness duration in specific frontal brain regions. Finally, our 
results highlight the potentially complex effects of the continued use of antipsychotic drugs on 
structural brain abnormalities in schizophrenia, as we found that cumulative doses of antipsychotics 
affected brain volumes globally rather than selectively on frontal-temporal regions.  
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Legends 
 
 
Figure 1. Results of VBM analyses showing GM reductions occurring in the combined group of 
chronic and first-episode schizophrenia patients (n= 161) versus controls (n= 151). Brain slices are in 
coronal planes, and the right hemisphere of the brain is on the right. Statistical parametric maps 
were thresholded at p<0.001 uncorrected for multiple comparisons with a minimum cluster extent of 
10 voxels. Findings are highlighted in the bilateral insulae, right striatum and left inferior frontal gyrus 
(significant at p<0.05, FWE-corrected over the whole brain), as well as in the bilateral dorsolateral 
prefrontal cortices, bilateral anterior cingulate cortices, bilateral thalami and left hippocampus/ 
parahippocampal gyrus (significant in SVC analyses at p<0.05, FWE-corrected) (see Table 4 for 
statistical and localization details).  
 
Figure 2. Results of VBM analyses showing GM reductions occurring in first-episode schizophrenia 
patients (n= 62) versus controls (n= 151) identified in SVC analyses at p<0.05, FWE-corrected. Brain 
slices are in coronal planes, highlighting findings in the bilateral insulae, right amygdala, right 
striatum and right hippocampus/ parahippocampal gyrus. The right hemisphere of the brain is on the 
right. Statistical parametric maps were thresholded at p<0.001 uncorrected for multiple comparisons 
with a minimum cluster extent of 10 voxels. 
 
Figure 3. Results of VBM analyses showing GM reductions occurring in chronic schizophrenia patients 
(n= 99) versus controls (n= 151) (panel A), and chronic versus first-episode schizophrenia patients (n= 
62), without covariation for age of onset (panel B). Brain slices are in axial planes in order to display 
the generalized findings of cortical and subcortical volumetric reductions in chronic patients; the 
right hemisphere of the brain is on the right. Statistical parametric maps were thresholded at 
p<0.001 uncorrected for multiple comparisons with a minimum cluster extent of 10 voxels. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
 
 
 
 
 
 
 
Table 1. Scanning Sequences Used in Each Magnetic Resonance Imaging Study 
 
Study Author (year) 
N Type of 1.5T MRI Scanner MRI Scan Sequence Parameters 
Patients Controls Total Vendor Model Sequence 
TR 
(ms) 
TE 
(ms) 
FA Orientation 
Thickness 
(mm) 
Field of 
view 
Matrix 
size 
1 Sallet et al. (2003) 35 15 50 Philips 
Gyroscan S15-
ACS 
FFE 30 9 30° Coronal 1.2 240 256 x 256 
2 
de Souza Crippa et al. 
(2006) 
20 16 36 Siemens Magneton Vision FLASH 9.7 4 12° Sagittal 1.0 256 256 x 256 
3 
Schaufelberger et al. 
(2007) 
62 94 156 
General 
Electric 
Signa Horizon SPGR 21.7 5.2 20° Axial 1.5 220 256 x 192 
4 Bassitt et al. (2007) 44 26 70 
General 
Electric 
Signa Horizon SPGR 9 1.9 20° Sagittal 1.2 220 256 x 192 
 
TR = repetition time; TE = echo time, FA = flip angle. 
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Table 2. Demographic and Clinical Characteristics of Schizophrenia Patients and Controls 
 
Characteristic 
Schizophrenia Patients Statistical Analysis
a
 
Controls 
(N=151) 
Statistical Analysis
b
 
Chronic 
(N=99) 
First-Episode 
(N=62) 
Total 
(N=161) 
t or 
χ2 
df p t or χ2 df p 
Gender, n (%)  
      Male 67 (67.7) 44 (31.0) 111 (68.9) 
0.19 1 0.728 
87 (57.6) 
4.31
a
 1 0.038 
      Female 32 (32.3) 18 (69.0) 50 (31.1) 64 (42.4) 
Age, years: mean ± s.d.  32.1 ± 8.0  27.7 ± 8.1 30.4 ± 8.3 3.42 129.45 0.001 
30.6 ± 
9.0 
-0.18 304.15 0.857 
Education, years: mean ± s.d. 10.1 ± 3.1 8.6 ± 3.8 9.5 ± 3.5 2.47 110.17 0.01 
10.7 ± 
4.7 
-2.57 310 0.011 
Age of onset, years: mean ± s.d. 20.2 ± 5.2 26.8 ± 8.1 22.7 ± 7.2 
-
6.21 
159 <0.0001 
 Duration of illness, years: median ± s.d. 11.0 ± 8.2 0.48 ± 1.2 5.0 ± 8.5 10.7 159 <0.0001 
PANSS score, total 
c
: mean ± s.d. 62.6 ± 18.4 
c
 47.8 ± 11.9 56.1 ± 17.4 
c
 5.48 139 <0.0001 
Antipsychotics   
      Typical, n (%) 15 (15.2) 43 (69.4) 58 (36.0) 
48.6 1 <0.0001 
       Atypical, n (%) 84 (84.8) 19 (30.6) 103 (64.0) 
      Estimated life-time cumulative                                                           
exposure, dose-years 
d
: mean ± s.d. 
4331.5 ± 
4988.2 
162.4 ± 
568.5 
2726.0 ± 
4416.5 
6.55 159 <0.0001 
 
(a) Chronic vs. first-episode schizophrenia patients and (b) total schizophrenia patients group vs. controls; continuous variables were analyzed through the t test and categorical variables through Pearson’s χ2 
test. (c) Data not available for one study (ref. 35). (d) Estimated life-time cumulative antipsychotics exposure expressed in dose-years after transformation in mg of chlorpromazine equivalents (Andreasen 
et al. 2009). 
 
PANSS = Positive and Negative Syndrome Scale 
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Table 3. Comparison of Global Brain Volumes Between Schizophrenia Patients and Controls 
 
Global volumes 
Schizophrenia Patients Statistical Analysis
a
 
Controls 
(N=151) 
Statistical Analysis
b
 
Chronic 
(N=99) 
First-Episode 
(N=62) 
Total 
(N=161) 
t df p t  df p 
 
Global GM volume (mm³): mean ± s.d. 667.71 ± 65.6 671.39 ± 79.2 669.13 ± 70.9 - 0.32 159 0.750 661.94 ± 70.2 0.90 310 0.369 
Global WM volume (mm³): mean ± s.d. 507.21 ± 55.3 520.10 ± 64.1 512.17 ± 59.0 -1.31 115.56 0.194 509.77 ± 57.7 0.36 310 0.717 
Global CSF volume (mm³): mean ± s.d. 301.05 ± 36.9 275.55 ± 37.1 291.23 ± 38.9 4.25 159 <0.0001
*
 276.79 ± 41.9 3.14 310 0.002 
TBV (mm³): mean ± s.d. 1174.93 ± 117.7 1191.49 ± 141.8 1181.31 ± 127.3 - 0.80 159 0.424 1171.71 ± 124.7 0.67 309 0.502 
TIV (mm³): mean ± s.d. 1475.98 ± 146.6 1467.05 ± 174.0 1472.54 ± 157.3 0.35 159 0.727 1448.51 ± 158.0 1.34 308 0.180 
 
(a) Chronic vs. first-episode schizophrenia patients and (b) total schizophrenia patients group vs. controls. Continuous variables were analyzed through the t test  
* This result did not remain statistically significant when analysis was corrected for the effect of age of onset (p=0.590)  
 
GM = gray matter; WM = white matter; CSF = cerebrospinal fluid; TBV = total brain volume; TIV = total intracranial volume 
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Table 4.  Regional gray matter volume reductions schizophrenia patients (chronic + first-episode groups) 
relative to controls based on voxel-based morphometry analyses. 
 
Anatomical region 
Number of voxels in 
each cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of maximal statistical 
significance (MNI space) 
Whole brain analysis (FWE-corrected at p<0.05) 
Left insula, left inferior frontal cortex 706 6.03 -35, 23, 1 
Right insula, right striatum 104 5.09 45, 11, -6 
Additional findings based on small volume-corrected analyses (FWE-corrected at p<0.05) 
Right dorsolateral prefrontal cortex 1051 4.23 21 ,59, 6 
Left dorsolateral prefrontal cortex 643 5.96 -38, 35, 1 
Right anterior cingulate cortex 165 3.66 2, 51, 13 
Left anterior cingulate cortex 61 4.46 -3 ,53, 12 
Right thalamus 179 4.03 2, -13, 6 
Left thalamus 90 3.94 0, -13, 6 
Left hippocampus/parahippocampal 
gyrus 
120 3.75 -30, -30, 15 
(a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
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Table 5. Regional gray matter volume reductions in first-episode schizophrenia patients relative to controls 
based on voxel-based morphometry analyses. 
 
 
Anatomical region 
Number of voxels in 
each cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of maximal 
statistical significance (MNI space) 
Findings based on small volume-corrected analyses (FWE-corrected at p<0.05) 
Right striatum 49 3.67 27, 5, -11 
Right hippocampus/parahippocampal 
gyrus 
199 4.23 33, -34, -17 
Right amygdala 84 4.04 27, 5, -15 
Right insula  28 3.55 42, 11, -14 
Left insula 29 3.64 -35, 15, -17 
 
(a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
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Table 6. Regional gray matter volume reductions in chronic schizophrenia patients relative to controls based on 
voxel-based morphometry analyses. 
 
 
Anatomical region 
Number of 
voxels in each 
cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of 
maximal statistical 
significance (MNI space) 
Whole brain analysis (FWE-corrected at p<0.05) 
Bilateral hemisphere cluster, including: bilateral superior and 
orbital frontal cortices, right middle frontal cortex, bilateral 
anterior cingulate cortices  
8616 7.01 11, 47, 10 
Left insula, left inferior frontal cortex 1203 6.43 -38, 35, 1 
Right insula, right inferior frontal cortex 510 6.19 44, 18, -5 
Right superior and middle temporal cortices 1496 5.84 53, -24, -5 
Left postcentral gyrus 49 5.54 -41, -24, 43 
Left fusiform gyrus 77 5.22 -36, -43, -14 
Right thalamus 25 5.19 11, -10, 3 
Right supramarginal gyrus 46 5.01 46, -45, 42 
Left precentral gyrus 20 4.92 -48, -3, 37 
Right calcarine gyrus 28 4.88 11, -63, 10 
Left median cingulate and paracingulate gyrus 22 4.87 -9, -7, 48 
Left hippocampus/parahippocampal gyrus 27 4.78 -27, -34, -12 
Additional findings based on small volume-corrected analyses (FWE-corrected at p<0.05) 
Left thalamus 129 6.43 -9, -7, 3 
Right hippocampus/parahippocampal gyrus 69 5.19 14, -6, -20 
Right temporal superior gyrus 898 4.26 53, -24, -5 
 
(a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
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Table 7. Regional gray matter volume reductions in chronic schizophrenia patients relative to first-episode 
schizophrenia patients based on voxel-based morphometry analyses. 
 
Anatomical region 
Number of 
voxels in each 
cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of 
maximal statistical significance 
(MNI space) 
Whole brain analysis (FWE-corrected at p<0.05) 
Left superior temporal cortex, extending to left 
precentral and postcentral cortices  
2642 7.42 -41, -25, 6 
Right superior and middle temporal cortices, extending 
to right supramarginal and angular gyri 
5830 7.22 46, -46, 48 
Left middle temporal cortex, extending to left angular 
gyrus  
841 7.15 -44, -64, 22 
Left superior and inferior parietal cortices 665 7.06 -29, -48, 54  
Left inferior temporal cortex, extending to left 
parahippocampal gyrus and left inferior occipital, 
fusiform and lingual cortices 
1508 6.79 -36, -52, -3 
Left precentral cortex 245 6.42 -30, -13, 45 
Left postcentral cortex 256 6.26 -33, -31, 54 
Left inferior frontal cortex 294 5.89 -29, 33, -3 
Left insula 108 5.12 -41, 5, 12 
Additional findings based on small volume-corrected analyses (FWE-corrected at p<0.05) 
Right thalamus 905 6.16 11, -10, 3 
Right amygdala 330 5.42 -6, 6, -3 
 
 (a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
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Table 8. Regional gray matter volume reductions in chronic schizophrenia patients relative to first-episode 
schizophrenia patients based on voxel-based morphometry analyses after correction for the confounding effect 
of age of onset. 
 
Anatomical region 
Number of voxels 
in each cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of maximal 
statistical significance (MNI space) 
Whole brain analysis (FWE-corrected at p<0.05) 
Left precentral cortex 238 7.09 -48, -4, 40 
Right calcarine, precuneus, cuneus and lingual 
cortices 
1166 6.95 12, -63, 13 
Right superior and middle temporal cortices 3206 6.76 45, -4, -24 
Left superior temporal cortex 1228 6.45 -41, -27, 6 
Right inferior parietal cortex, extending to 
right supramarginal and angular gyri 
552 6.27 46, -46, 48 
Left middle temporal cortex 367 6.18 -44, -64, 22 
Left superior and inferior parietal cortices 163 6.16 -27, -48, 54 
Righ thalamus 54 5.88 11, -10, 3 
Left postcentral cortex 45 6.26 -44, -24, 46 
Right superior frontal cortex 177 5.50 9, 39, 46 
Right inferior frontal cortex 33 5.24 33, 30, -11 
Additional findings based on small volume-corrected analyses (FWE-corrected at p<0.05) 
Right anterior cingulate cortex 2629 6.72 17, 44, 19 
Left anterior cingulate cortex 2131 7.42 -5, 51, -2 
Left striatum 323 5.22 -6, 6, -3 
Right hippocampus/ parahippocampal gyrus 319 6.48 42, -16, -14 
Left hippocampus/ parahippocampal gyrus 485 5.58 -24, -39, -8 
Right insula 274 4.33 45, 18, -5 
Left insula 298 3.90 -36, 0, 6 
Left thalamus 181 5.70 -9, -6, 4 
 
 (a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
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Table 9. Results of small volume-corrected analyses (FWE-corrected at p<0.05) showing positive correlations 
between gray matter regional volumes and age of onset in the conjoined groups 
 
Anatomical region 
Number of voxels 
in each cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of maximal 
statistical significance (MNI space) 
All patients 
*
 
Right dorsolateral prefrontal cortex 740 5.19 42, 15, 15 
Left dorsolateral prefrontal cortex 221 4.30 -32, 29, 12 
Right anterior cingulate cortex 475 3.87 17, 42, 21 
Left anterior cingulate cortex 174 3.69 -2, 53, 3 
Right insula 108 4.16 46, 12, 3 
Left insula 1190 4.31 -30, 29, 12 
Right hippocampus/ parahippocampal gyrus 286 4.07 36, -34, -5 
Right superior temporal gyrus 395 4.23 60, -48, 22 
Conjunction of three groups with available PANSS total scores 
ꭥ
  
Right dorsolateral prefrontal cortex 204 4.34 18, 42, 24 
Left dorsolateral prefrontal cortex 106 3.90 -32, 29, 12 
Left anterior cingulate cortex 103 3.51 -2, 54, -2 
Left insula 189 3.80 -30, 29, 12 
Right hippocampus/ parahippocampal gyrus 252 3.77 36, -34, -3 
Right superior temporal gyrus 451 4.37 60, -49, 22 
First-episode 
µ
 
Right superior temporal gyrus 21 3.78 42, -31, 4 
 
(a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
* after accounting for effects of lifetime cumulative exposure to antipsychotics 
ꭥ after accounting for effects of lifetime cumulative exposure to antipsychotics and overall illness severity 
µ after accounting for effects of lifetime cumulative exposure to antipsychotics and duration of disease 
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Table 10. Results of small volume-corrected analyses (FWE-corrected at p<0.05) showing negative correlations 
between gray matter regional volumes and duration of disease in the conjoined and first-episode groups 
 
Anatomical region 
Number of voxels 
in each cluster 
Peak Z 
score 
a
 
Co-ordinates of voxel of maximal 
statistical significance (MNI space) 
All patients 
*
 
Right insula 162 4.11 48, 8, 6 
Left insula 1583 4.33 -42, 5, 10 
Right dorsolateral prefrontal cortex 934 4.85 51, 15, 7 
Left dorsolateral prefrontal cortex 632 4.23 -41, 6, 10 
Right hippocampus/ parahippocampal gyrus 226 3.86 8, 26, 21 
Left hippocampus/ parahippocampal gyrus 113 3.64 -27, -30, -6 
Conjunction of three groups with available PANSS total scores 
ꭥ
  
Right insula 62 3.60 48, 8, 6 
Left insula 806 3.78 -29, 29, -3 
Right dorsolateral prefrontal cortex 1015 4.61 18, 44, 24 
Left dorsolateral prefrontal cortex 286 3.82 -30, 35, -2 
Right hippocampus/ parahippocampal gyrus 123 4.19 29, -19, -9 
Left hippocampus/ parahippocampal gyrus 190 3.77 -27, -34, -9 
Right anterior cingulate cortex 23 4.07 17, 45, 21 
Left anterior cingulate cortex 112 3.91 -3, 53, 1 
Conjunction of three groups with available PANSS total scores 
µ
 
Right dorsolateral prefrontal cortex 258 3.94 28, 15, 52 
First-episode 
µ
 
Left superior temporal gyrus 108 3.82 -54, -24, 10 
 
(a) Z score for the voxel of maximal statistical significance in each cluster.  
MNI = Montreal Neurological Institute; FWE = family-wise error 
* after accounting for effects of lifetime cumulative exposure to antipsychotics 
ꭥ after accounting for effects of lifetime cumulative exposure to antipsychotics and overall illness severity 
µ after accounting for effects of lifetime cumulative exposure to antipsychotics, overall illness severity and age of onset 
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Fig. 2 
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Fig. 3 
 
 
Highlights 
Structural brain changes are more widespread in chronic than first-episode schizophrenia. 
Regional GM deficits may be greater in cases with earlier age of onset. 
Illness duration seems to impact in some specific frontal structural brain changes.  
Antipsychotics seem to affect brain volumes globally rather than regionally. 
